Page 1

HERBALIFE C NUTRITION Herbalife Nutrition Reports Third Quarter 2021 Results and on Track for Another Record Year LOS ANGELES , November 2nd , 2021 - Herbalife Nutrition Ltd. ( NYSE : HLF ) today reported financial results for the third quarter ended September 30 , 2021 : HIGHLIGHTS ■ Third quarter 2021 net sales of $ 1.4 billion , a 6 % decrease compared to the third quarter 2020 and in - line with guidance issued on September 13 , 2021 . Third quarter 2021 reported diluted EPS of $ 1.09 and adjusted ¹ diluted EPS of $ 1.21² , compared to $ 1.04 and $ 1.152 , respectively , for the third quarter 2020. Third quarter 2021 reported and adjusted earnings per share both increased by approximately 5 % compared to the third quarter 2020 . Third quarter 2021 reported net income of $ 117.4 million and adjusted¹ EBITDA of $ 222.4 million . Third quarter 2021 adjusted¹ diluted EPS and adjusted¹ EBITDA exceeded the high - end of the guidance ranges issued on September 13 , 2021 . Reiterating FY 2021 outlook for the top and bottom line , including net sales guidance range of 4.5 % to 8.5 % growth , adjusted³ diluted EPS guidance range of $ 4.55 – $ 4.95 , and adjusted³ EBITDA guidance of $ 860 million - $ 910 million . During the third quarter , the Company repurchased approximately 3.5 million shares for a total of $ 162 million . " Over the course of the global pandemic , we have delivered unprecedented business performance and growth . Despite challenging comparison periods in the third and fourth quarters , we remain on track for another record sales year . " - John Agwunobi , Chairman and CEO of Herbalife Nutrition ¹ Adjusted diluted EPS and adjusted EBITDA are non - GAAP measures . See Schedule A - " Reconciliation of Non - GAAP Financial Measures " for a detailed reconciliation of these measures to the most directly comparable GAAP measure , and a discussion of why we believe these non - GAAP measures are useful . 2 Third quarter 2021 results were impacted by expenses related to the China Growth and Impact Investment Program of approximately $ 4.1 million or $ 0.03 per diluted share . Third quarter 2020 results were impacted by China grant income of approximately $ 0.6 million , or $ 0.00 per diluted share and expenses related to the China Growth and Impact Investment Program of approximately $ 3.2 million or $ 0.02 per diluted share . Third quarter 2020 adjusted results have been updated in Schedule A to no longer exclude China grant income . 3 Adjusted diluted EPS and adjusted EBITDA are non - GAAP measures . See the " Outlook " discussion below and the related footnotes and Schedule A - " Reconciliation of Non - GAAP Financial Measures " for additional information regarding adjusted diluted EPS and adjusted EBITDA guidance .